相关实验视频

Updated: Jul 28, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌中的EZH2:进展,免疫力和潜在的向疗法

Bohan Wang¹, Yachong Liu¹, Zhibin Liao¹

¹Hepatic Surgery Center, Institute of Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Experimental hematology & oncology

|June 2, 2023

概括

增强体同源2 (EZH2) 驱动肝细胞癌 (HCC) 的进展和转移通过表观遗传改变. EZH2抑制剂通过向瘤免疫力和细胞生长,对HCC治疗具有前途.

科学领域:

在瘤学瘤学.
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
分子生物学分子生物学

背景情况:

肝细胞癌 (HCC) 是癌症死亡的主要原因.
遗传和表观遗传改变是HCC发展的关键驱动因素.
增强体质同源2 (EZH2) 通过表观遗传修饰与瘤发生有关.

研究的目的:

审查EZH2在HCC中的多方面的作用.
探索EZH2在HCC细胞增殖和转移中的作用.
总结EZH2抑制剂在HCC治疗中的治疗潜力.

主要方法:

对HCC中EZH2的最近研究的文献综述.
分析EZH2在HCC进展中的功能.
检查EZH2对瘤免疫力的影响.
在HCC治疗中对EZH2抑制剂应用的评估.

主要成果:

EZH2对HCC细胞的增殖和转移有显著的作用.
EZH2在调节瘤免疫微环境方面发挥着至关重要的作用.
在临床前的HCC模型中,EZH2抑制剂显示出潜在的疗效.

结论:

EZH2是HCC病变发生过程中的关键表观遗传调节剂.
向EZH2为HCC提供了一个有前途的治疗策略.
对EZH2抑制剂的进一步研究可能会导致新的HCC治疗方法.

关键词:

在 EZH2 中使用.这是一种EZH2抑制剂.在HCC中,HCC是HCC,HCC是HCC.豁免权是一种豁免权.

更多相关视频

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...